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Abstract: Intrinsically disordered proteins (IDPs) can form functional oligomers and in some cases,
insoluble disease related aggregates. It is therefore vital to understand processes and mechanisms
that control pathway distribution. Divalent cations including Zn2+ can initiate IDP oligomerisation
through the interaction with histidine residues but the mechanisms of doing so are far from
understood. Here we apply a multi-disciplinary approach using small angle X-ray scattering, nuclear
magnetic resonance spectroscopy, calorimetry and computations to show that that saliva protein
Histatin 5 forms highly dynamic oligomers in the presence of Zn2+. The process is critically dependent
upon interaction between Zn2+ ions and distinct histidine rich binding motifs which allows for
thermodynamic switching between states. We propose a molecular mechanism of oligomerisation,
which may be generally applicable to other histidine rich IDPs. Finally, as Histatin 5 is an important
saliva component, we suggest that Zn2+ induced oligomerisation may be crucial for maintaining
saliva homeostasis.
Keywords: Intrinsically disordered proteins; oligomerisation; Histatin; NMR; SAXS; computer
simulation
1. Introduction
It has been firmly established that intrinsically disordered proteins (IDPs) regulate many biological
processes [1]. IDPs do not rely on a well-defined three-dimensional structure to perform their cellular
functions but instead sample a heterogeneous ensemble of conformations [2,3]. The functions of IDPs
often involve interactions with other macromolecules [4]. These interactions can be regulated through
biological processes such as post-translational modification [5,6] but also through interactions with
other molecules including divalent metal ions such as Ni2+, Cu2+, and Zn2+ [7,8]. In many cases these
interactions are directly related to the biological function of the protein [9]. For example, a group
of intrinsically disordered phosphoproteins including casein and osteopontin interact with calcium
phosphate in milk through phosphorylated residues, thereby stabilising the fluid [10–13]. Another
example is statherin, a saliva protein that transports calcium and magnesium to the enamel, a crucial
process required to maintain the mineral phase of teeth [14,15].
Under physiological conditions some IDP monomers can undergo oligomerisation driven either
by self-association or through interaction with multivalent ions and biological macromolecules such
as RNA or DNA [16]. The process of oligomerisation can be functionally important but may in some
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cases lead to the formation of insoluble disease-related aggregates [17,18]. An example of this is the
histidine rich Aβ peptide where conformational changes of the protein can result in the formation
of toxic soluble dimers, which in turn oligomerise, resulting in the formation of insoluble protein
aggregates that are the hallmarks of Alzheimer’s disease [18,19]. In the case of Aβ, oligomerisation is
driven by the interaction between the N-terminal Aβ 1-16 region and Zn2+ ions [20,21].
Histatin 5 (Hst5) is another histidine rich peptide found in saliva where it acts as first line of
defence against oral candidiasis caused by Candida albicans [22–24]. In solution, Hst5 behaves as
an IDP [25,26], but secondary structure elements can be induced under certain conditions [22,24,27].
Inherently, saliva contains various transition metals such as calcium, magnesium, zinc, nickel, copper,
and iron [28]. Hst5 has been shown to bind Zn2+, Cu2+, and Fe2+/3+ ions [29–31], and it possesses
defined metal binding motifs for copper (DSH, termed the ACTUN motif), nickel (DSH, ACTUN
motif) [29], and zinc (a HExxH motif) [30]. Figure 1 displays the zinc-binding motif as well as the
possible zinc-binding motif we suggest as a result of this article, to be discussed later.
DSHAKRHHGYKRKFHEKHHSHRGY
Possible 
motif
Zn(II)
HExxH
Zn(II)
Figure 1. Primary structure of Hst5 with two of the zinc-binding motifs highlighted. The suggested
possible zinc binding motif will be further discussed in the results section.
Recent experimental work has shown that the interaction between Aβ and Zn2+ proceeds through
two consecutive steps [20]: (i) primary Zn2+ binding by side chains of the histidine residues H6,
E11, H13, and H14 for a single peptide, where the latter three originates from a zinc motif similar
to the one present in Hst5, and (ii) dimerisation via zinc coordination of residues E11 and H14 in
the zinc-binding motif. Hence, after the dimerisation seed is formed, further build-up of oligomers
is due to Zn2+-histidine interactions through residues H6 and H13, see Figure 8 in the article by
Polashakov et al. [20]. Further, Barnham et al. [32] showed that the Zn2+-induced oligomers of Aβ
ranged in size from monomers to octamers, with one to three metal ions per peptide molecule [30],
and with a higher affinity for Cu2+ compared to that of Zn2+.
In this paper, we widen the studies of the interactions between IDPs and divalent ions with
an emphasis on Zn2+. We address the structural effects of Zn2+-binding to Hst5 with the overall
aim to investigate if any general behaviour could be captured regarding metal ion induced oligomer
formation of IDPs. For that purpose, parallels will be made to Aβ. By small angle X-ray scattering
(SAXS) in combination with nuclear magnetic resonance (NMR) spectroscopy, isothermal titration
calorimetry (ITC), and coarse-grained Monte Carlo (MC) simulations, we have confirmed that Hst5
binds Zn2+ and causes oligomer formation. By studying five different variants of Hst5, designed to
elucidate the effect of dynamic histidine coordination, we suggest a possible mechanism for oligomer
formation, and we hypothesise this to be a general mechanism for oligomerisation in the presence of
divalent cations of histidine rich IDPs.
2. Materials And Methods
2.1. Sample Preparation
Hst5 was purchased from American Peptide Company, CAS: [72-2-25] as well as Genemed
Synthesis, Inc with a purity between 97.0–99.0%. The five variants were purchased from TAG
Copenhagen A/S, Denmark, with a purity of 97.63%, 97.27%, 97.84%, 96.02%, and 96.15% for Hst5RAN,
Hst5DZM, Hst5ZM, Hst52H, and Hst5DH, respectively, measured by HPLC. For further explanation
regarding denotation of the variants, please see Figure 2.
Biomolecules 2019, 9, 168 3 of 20
Hst5
Hst5DZM
Hst5RAN
Hst5ZM
Hst52H
Hst5DH
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
D S H A K R H H G Y K R K F S H R G Y
H H Y A R K S D K H S F H Y G R H K H E R G K H
D S H A K R H H G Y K R K F Q E K Q Q S H R G Y
D S Q A K R Q Q G Y K R K F H E K H H S Q R G Y
D S Q A K R Q H G Y K R K F Q E K Q H S Q R G Y
D S Q A K R Q Q G Y K R K F Q E K Q Q S Q R G Y
Res Number
H E K H H} }
Possible motif HExHH motif
Figure 2. Primary structures of Hst5 and variants. The grey shaded areas denote the histidines and
the yellow shaded area with red letters denote the known zinc-binding motif. Hst5RAN—random
distribution of histidines, keeping the total number constant. Hst5DZM—The histidines in the zinc-motif
have been replaced by glutamines. Hst5ZM—The histidines of the zinc-binding-like motif have been
replaced by glutamines. Hst52H—Two histidines in the zinc-motif have been replaced by glutamines,
and only one of four histidines are left in the rest of the amino acid sequence. Hst5DH—All the histidines
are replaced by glutamines.
The 20 mM MES buffer (Sigma with a purity of >99.5 Milli-Q water, and pH was adjusted
with NaOH. The ionic strength of the solutions was adjusted with NaCl (Scharlau with a purity of
>99.598.5 was filtered through a 0.2 µm hydrophilic polypropylene membrane (Pall Corporation, New
York, NY, USA). After mixing the protein powder with the buffer, a concentration cell (Vivaspin 20,
MWCO 2 kDa, Prod. No. VS2002, Sartorius Stedim Biotech GmbH, Goettingen, Germany), was used
to remove low molecular weight impurities including ions from the freeze-dried sample. The samples
were rinsed with buffer corresponding to at least 30 times the sample volume. To ensure exact match
of the background, the samples were dialysed for 24 h (Slide-A-Lyzer MINI, MWCO 2 kDa, Prod. No.
69580, Thermo Scientific, Waltham, MA, USA).
2.2. SAXS
Prior to the SAXS measurements, the samples were centrifuged with an ultracentrifuge (rotor
TLA55) at 13,000 rpm for at least 30 min to remove large aggregates. A Nanodrop spectrophotometer
was used to measure the protein concentrations, ε= 2560 M−1cm−1 , λ= 280 nm, immediately prior
to SAXS measurements. To obtain the form factors at all ionic strengths, and decent signal to noise
ratios, the protein concentrations were set to 0.5–6.0 mg/mL. At least three concentrations for each
sample condition were measured to ensure no concentration dependence. The ionic strength was set
from 12 to 300 mM by varying the NaCl concentration. SAXS measurements were carried out using
the BM29 beamline at the European synchrotron facility ESRF in Grenoble, France. The incident beam
wavelength was 0.99Å, the distance between the sample and the PILATUS 1M detector was set to
2864 mm, and the scattering vector range was 0.0036 Å−1 < q > 0.49 Å−1. The scattering vector was
defined as q = 4pisinθλ , where 2θ is the scattering angle. For each sample and pure solvent, several
successive frames (typically 10–25) of 1–2 s each, were recorded, enabling detection of radiation
damage prior to further processing of the data. The background (pure solvent) was measured before
and after the sample, and the average was subtracted from the signal from of the corresponding sample
solution. The temperature was set to 20 ◦C and I(0) was converted to absolute scale by measuring the
scattering of water. The software Primus from the ATSAS package [33] was utilised for data inspection
and analysis. The radius of gyration was determined for each sample by Guinier analysis, where
q · RG <= 0.8. The distance distribution functions were calculated using GNOM and used as input for
the ab initio envelope reconstruction program DAMMIF [34]. Twenty independent reconstructions
were completed using DAMMIF, the results were checked for consistency, averaged and filtered back
to the volume of the original models. Fits of the calculated envelope to the scattering curve are shown
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in Supplementary Figure S4. The goodness fit of the experimental scattering curve to the computer
simulation was determined by calculating χ2:
χ2 =
1
Np
Np
∑
i=1
[
Iexp − Isim
Isim
]2
, (1)
where Np is the number of data points, Iexp is the experimental scattering data, and Isim the simulated
scattering data.
2.3. NMR
All NMR experiments were acquired on a Bruker Avance III 600 MHz (1H) spectrometer equipped
with a TCI cryogenic probe. Pulsed Field Gradient (PGF) diffusion experiments were recorded on
samples containing 1 mM Hst5 in 20 mM MES pH 6.7, 150 mM NaCl, 10% D2O, and 0.25% (v/v)
1,4-Dioxane at 20 ◦C. In low pH experiments, the MES buffer was replaced with 20 mM sodium acetate
pH 4.0. For experiments involving Zn2+, 4 mM ZnCl2 was added to the buffer. A standard Bruker
PFG-longitudinal eddy current delay sequence with bipolar gradients and solvent pre-saturation
during the relaxation delay of 3 s was used [31]. A total of 32 spectra with gradients strengths ranging
from 2% to 98% of its maximum value were recorded. A diffusion time Δ of 200 ms and gradient
length δ of 2 ms were used in all experiments. The pseudo 2D data was Fourier transformed and
baseline corrected in Topspin (Bruker, Billerica, MA, USA), and subsequently analysed in Dynamics
Center (Bruker). The diffusion constants were determined by fitting of peak intensity decays using the
Stejskal-Tanner equation:
I = I0e−g
2γ2δ2(∆− δ3 )D (2)
where I is the intensity, g is the gradient strength, γ the gyromagnetic ratio of 1H, δ the gradient length,
∆ the diffusion time, and D the diffusion constant. The diffusion constants from a selection of peaks
in the aromatic and aliphatic side-chain regions were plotted as histograms and fitted to a Gaussian
function using:
f (x) = A · e−
(x−µ)2
2σ2 , (3)
where µ is the mean, σ the standard deviation, and A is the amplitude. Different bin sizes where
evaluated to check for robustness of the extracted parameters. 1,4-dioxane with a known hydrodynamic
radius of 2.12 Å was used as an internal reference and used for the calculation of Rh according to
Wilkins et al. [35]:
Rh,prot =
Dref
Dprot
· Rh,ref, (4)
2.4. Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) experiments were carried out using a MicroCal ITC200
(GE Healthcare) at 20 ◦C. Prior to each experiment, samples were centrifuged at 20.000 g for 10 min
followed by degassing for 15 min. In each titration either, Hst5, Hst5ZM or Hst5DZM at concentrations
ranging from 150–300 µM were placed in the cell, and ZnCl2 in the syringe at a concentration of
3.52 mM. The experiments were performed in 20 mM MES (pH 6.7), 150 mM NaCl. After an initial
delay of 180 s, 18 injections of 2 µL ZnCl2 solution was titrated into Hst5 or variant, with each injection
separated by 180 s. The heat of dilution was measured in control experiments without Hst5 and was
subtracted from the raw data. The thermodynamic parameters were obtained by fitting the data to
a single-site binding model within the Origin software (MicroCal, MA, USA). All experiments were
performed in triplicates or more, and the average values are given with standard errors of the mean in
Table 1.
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Table 1. Thermodynamic analysis of Zn2+ binding to Hst5 and variants. All experiments were
performed as described under “Experimental Procedures” and represent the average of three
independent experiments.
Kd (µM ) N ΔH (kJ/mol) −TΔS (kJ/mol) ΔG (kJ/mol)
Hst5 26± 1 1.18± 0.01 −23.8± 0.3 −2.0± 0.3 −25.8± 0.1
Hst5DZM 45± 9 0.89± 0.06 −3.1± 0.3 −21.3± 0.5 −24.4± 0.5
Hst5ZM 61± 10 0.94± 0.04 −2.6± 0.2 −21.1± 0.4 −23.7± 0.4
2.5. Coarse-Grained Model
Previous studies completed in the Skepö group have shown that there is a good agreement
between the Monte-Carlo approach and more detailed atomistic molecular dynamics simulations
using Gromacs [26,36]. Despite the fact that the coarse grained approach provides a less detailed
description, the main advantage of using this model is the ability to study intermolecular and
multibody interactions. The individual residues of the proteins, i.e., the amino acids, were represented
by hard spheres (beads) that mimic their excluded volume including the hydration layer, and were
connected via harmonic bonds [14]. The N- and C-termini were explicitly included to account for
the extra charge. The bead radius was set to 2 Å providing a realistic contact separation between
the charges and an accurate Coulomb interaction. The non-bonded spheres interacted through
a short-ranged attractive interaction as well as electrostatic interactions, where the interparticle
electrostatic interactions were described on the Debye-Hückel level. The simulations were performed
at constant pH with point charges. Each monomer was either charged, or neutral, depending on
the amino acid sequence. The total potential energy of the simulated system contained bonded and
non-bonded contributions, and was given by:
Utot = Unonbond +Ubond = Uhs +Uel +Ushort +Ubond, (5)
where the non-bonded energy was assumed to be pairwise additive according to:
Unonbond =∑
i<j
uij(rij), (6)
where rij = |Ri − Rj| is the center-to-center distance between two monomers, and R refers to the
coordinate vector. The excluded volume was taken into account through the hard-sphere potential,
Uhs, given by:
Uhs =∑
i<j
uhsij (rij), (7)
which sums up over all amino acids. The hard-sphere potential between two monomers in the model
was given by:
uhsij (rij) =
{
0, rij≥Ri+RJ
∞, rij<Ri+RJ
}
(8)
where Ri and Rj denote the radii of the beads. The electrostatic potential was given by an extended
Debye-Hückel potential according to:
Uel =∑
ij
uelij
(
rij
)
=∑
i<j
zizje2
4e0er
· exp
[−κ (rij (Ri − Rj))]
(1 + κRi)
(
1 + κRj
) · 1
rij
, (9)
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where e is the elementary charge, κ denotes the inverse Debye screening length, e0 is the vacuum
permittivity, and er the dielectric constant for water. The short-ranged attractive interaction between
the monomers was included through an approximate arithmetic average over all amino acids, given by:
Ushort = −∑
i<j
e
r6ij
, (10)
where e reflects the polarisability of the proteins, and thus sets the strength of the interaction. In this
model, e was set to 0.6 · 104 kJ Å6/mol, giving an attractive potential of 0.6 kT at closest contact.
The bonded interaction, a harmonic bond, was given by:
Ubond =
N−1
∑
i=1
kbond
2
· (ri,i+1 − r0)2 , (11)
where ri,i+1 denotes the distance, in Å, between two connected monomers with the equilibrium
separation r0 = 4.1 Å. The force constant is set to kbond = 0.4 N/m, whereas N denotes the number of
monomers of the protein. The proteins were assumed to be totally flexible.
The self-association of the wild type (WT) peptide and of its variants upon addition of Zn2+
were modelled by adding a short-ranged interaction between the monomers that were expected to
be involved in the association process, utilising Equation (10). The interaction strength, e, was set to
3.0 · 104 kJ Å6/mol, giving an attractive potential of 3.0 kT at closest contact.
2.6. Simulation Aspects
The equilibrium properties of the model systems were obtained by applying Monte Carlo
simulations in the canonical (NVT) ensemble, that is, constant volume, number of particles,
and temperature (T = 298 K), utilising the Metropolis algorithm. The protein chains were enclosed
in a cubic box with a box length at least 30 times longer than the radius of gyration of the protein.
Periodic boundary conditions were applied in all directions. The long-ranged Coulomb interactions
were truncated using the minimum image convention. Four different types of displacements were
allowed: (i) translational displacement of a single bead, (ii) pivot rotation, (iii) translation of the entire
chain, and (iv) slithering move, in order to accelerate the examination of the configurational space [32].
The probability of the different trial moves was weighted to enable single-particle moves 20 times more
often than the other three. Initially, the protein was randomly placed in the box and an equilibrium
simulation of typical 2 · 105 trial moves/bead was performed, whereas the proceeding production run
comprised 2 · 106 passes divided into ten subdivisions. The acceptance ratio in the simulations added
up to a total of approximately 30%. The radius of gyration and the end-to-end distance probability
distribution functions of the proteins i.e., the conformational ensembles, were analysed to confirm
that the simulations were sampled accurately. The reported uncertainty of simulated quantities is one
standard deviation of the mean. It is estimated from the deviation among the means of the subdivisions
of the total number of MC passes according to:
σ2(〈x〉) = 1
ns(ns − 1) ·
ns
∑
s=1
(〈x〉s − 〈x〉)2 , (12)
where 〈x〉s is the average of quantity x from one subdivision, 〈x〉 the average of x from the total
simulation, and ns the number of subdivisions used which here is 10. The simulations were performed
by using the integrated Monte Carlo/molecular dynamics/Brownian dynamics simulation package
Molsim [37].
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2.7. Structural Analysis
The model was validated by comparing the simulated scattering intensities with the experimental
scattering intensities obtained by SAXS. For a system containing N identical scattering objects,
the structure factor is given by:
S(q) =
〈
1
n
∣∣∣∣∣ N∑j=1 exp(iq · rj)
∣∣∣∣∣
2〉
. (13)
The total structure factor can further be decomposed into partial structure factors given by:
sij(q) =
〈
1
(NiNj)
1
2
·
[
Ni
∑
i=1
exp(iq · ri)
]  Nj∑
j=1
exp(iq · rj)
〉 . (14)
The total and partial S(q) are related through:
s(q) =
Ni
∑
i=1
Nj
∑
j=1
(
NiNj
) 1
2
N
· Sij(q). (15)
For a point scatterer the form factor is constant, inferring that the scattering intensity is
proportional to the structure factor. In order to account for an approximate effective particle/residue
form factor, the scattering profile further needs an appropriate normalisation, such that I0 coincides
with the experimental scattering profile.
The average oligomer size as well as the oligomer size distribution were determined using a
geometrical definition, and we considered them as clustered if the distance between at least one amino
acid from one protein did not exceed 6 Å from another protein. The formation of an oligomer from the
SAXS-experiments have been determined by defining the ratio β, which corresponds to the forward
scattering, I0,Zn, normalised by the concentration for the protein clustered with Zn2+, Ccp,Zn, divided
by the forward scattering normalised with the protein concentration in the vicinity of Zn2+ i.e., I0 and
cp respectively, see Equation (16).
β =
I0,Zn/Ccp,Zn
I0/Cp
. (16)
Thus, β = 1 indicates no oligomer formation, whereas β > 1 does.
3. Results And Discussion
We have earlier shown that the form factor of Hst5 under physiological conditions can be obtained
at a concentration of 1 mg/mL, and that its solution behaviour is consistent with that of an IDP [25,26].
To investigate how the addition of Zn2+ to the histidine-rich protein changes its properties, we first
employed SAXS. In the absence of Zn2+, Hst5 is a monomer with an estimated MW of 2.9± 0.2 kDa
based on the normalised intensity function (Figure 3A). Addition of Zn2+ resulted in an increase of
I(0) corresponding to an increase in the measured molecular mass to 4.8± 0.4 kDa. Addition of Zn2+
furthermore led to a compaction of the overall protein as shown by the downward curvature in the
Kratky plot (Figure 3B). The compaction was also supported by a redistribution of the pair distance
distribution P(r) towards shorter distances in the protein, although no effect was observed on the
maximum interparticle distance of the chain (Figure 3C).
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Figure 3. SAXS analysis of Hst5 in the absence and presence of ZnCl2. (A) Comparison of the
intensity function normalised by concentration for 0.9 mg/mL Hst5, in 20 mM MES-buffer, pH 6.7,
150 mM NaCl and 4 mM ZnCl2. (B) SAXS data shown as a dimensionless Kratky plot. (C) Plot of the
intra-peptide distance distribution determined by indirect Fourier transform, for Hst5, with either
NaCl (purple curves) or with ZnCl2 (red curves). (D,E) Concentration dependent SAXS-measurements
of Hst5 in the presence of ZnCl2, showing the intensity curve normalised with protein concentration
and the corresponding Kratky plot.
Investigation of the concentration dependence of the SAXS profiles as seen in Figure 3D showed
that the mass-weighted distribution was affected by the protein concentration, and that the complexes
increased in size with increasing protein concentration. Furthermore, precipitation was observed for
high ratios of Zn2+:protein. The dimensionless Kratky plot (Figure 3E) showed that the oligomers
obtained a more compact shape when compared to the random coil formation for the monomer, which
was clearly visible for Hst5 at concentrations of 0.29 mg/mL. Furthermore, a plateau value was reached
at a peptide concentration of around 5 mg/mL.
To substantiate our observations further, we performed 1D 1H NMR measurements on Hst5
in the presence and absence of ZnCl2 (Figure 4 and Supplementary Figures S1 and S5). At pH 6.7,
the spectrum of Hst5 showed sharp lines and was relatively well-resolved (Figure 4A). In contrast,
addition of 4x molar excess of ZnCl2 caused severe line broadening, which could be due to formation
of oligomers, and thus a decrease in tumbling rate (Figure 4B). However, our SAXS data suggested only
a three-fold increase in molecular weight, which is not sufficient to induce this degree of broadening.
Thus, chemical exchange between different unbound/bound states at a rate similar to the difference
in resonance frequency between the different states is more likely to be the origin. Hst5 contains a
high number of histidines known to coordinate Zn2+. Their involvement in binding is supported by
the fact that no line broadening was observed upon addition of Zn2+ at pH 4, where the histidines
are protonated (Figure 4C,D). This observation is in line with SAXS experiments at pH 4, which did
not indicate any oligomerisation (data not shown). Hence, it is possible that Zn2+ binding does not
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require specific histidine residues or a specific structure, but shuffles between different binding sites in
a highly dynamic manner, resulting in the observed line broadening.
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Figure 4. 1H 1D NMR spectra of the aromatic region of Hst5 under different conditions. (A) pH
6.7, 150 mM NaCl, (B) pH 6.7, 150 mM NaCl, 4 mM ZnCl2 (C) pH 4.0, 150 mM NaCl and (D) pH 4.0,
150 mM NaCl, 4 mM ZnCl2. All spectra were recorded at 20
◦C.
3.1. Tracing the Interaction Through Variants
To achieve a more in-depth understanding of the oligomerisation and Zn2+ binding to Hst5,
and to address the possibility of dynamic Zn2+ coordination, we designed variants of Hst5, where
we modulated the number and position of the histidine residues. In this process, we noted that
Hst5 contains a zinc-binding-like motif, HAKRHH, in its N-terminal, and we therefore mutated this
orthogonal to the known motif. Additionally, we randomised the sequence of Hst5, leading to a total
of five different variants. For substitutions of the histidines, we chose glutamine with similar size,
atomistic chemical skeleton, and hydrogen bonding potential as histidine, and thus can be viewed
as a pH-insensitive histidine-analogue. The five variants, and their primary structures, are listed in
Figure 2.
Using SAXS and NMR, the conformational properties of WT Hst5 and the five variants were
measured and compared (Table 2). The Kratky plots, Figure 5, revealed that in the absence of Zn2+,
the WT Hst5 and variants obtained the same overall shape. This was confirmed by NMR diffusion
experiments, which showed a size of Rh of approximately 13 Å for all variants. Furthermore in line with
data published by Henriques et al. [38], the Rg\Rh ratio of ≈ 1 suggests that the solvation layer around
IDPs can be considered to be very small in comparison to structured proteins. The radii of gyration
obtained from SAXS indicated a minor effect on the extension of the peptides when changing the order
of the histidines as in Hst5RAN, but it was difficult to find a correlation and an underlying mechanism.
No correlation between the Rh (or the Rg) with the number of histidines was seen. We did observe
an overall correlation between the theoretical the Rg/Rh ratio as was calculated from the empirical
relation published previously [39] and the current data (supplementary Figure S6). Investigation of
the overall shape of Hst5 by inspection of the Kratky plots of the variants indicated that removal of
the zinc-motif (Hst5DZM) and/or the zinc-binding-like motif (Hst5ZM\Hst52H), diminished the effects
of Zn2+ on compaction (Figure 5), highlighting that the presence of both histidine motifs is vital for
this effect. Randomising the sequence also slightly reduced the compaction of Hst5 in the presence of
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Zn2+, suggesting that not only the amount of histidines, but also their relative position is important
for compaction. Interestingly, we could not detect any compaction of WT Hst5 nor or of Hst5RAN
using NMR, likely due to the extensive line broadening observed upon addition of Zn2+, deeming the
compacted conformation of Hst5 NMR invisible.
Table 2. Conformational properties from SAXS and NMR of Hst5 and variants. Experiments were
performed as described in the methods section. All results are given in the absence and in the presence
Zn2+, where Zn is added in the subscript to denote the latter.
(a)
cp(mg/mL) cp,Zn(mg/mL) Rg(Å) Rg,zn(Å) I0 I0,Zn NH β
Hst5 1.01 1.03 13.4± 0.01 11.5± 0.02 3.07± 0.036 8.22± 0.041 7 2.63
Hst5RAN 0.94 0.94 11.9± 0.06 11.1± 0.09 3.47± 0.062 6.80± 0.062 7 1.96
Hst5DZM 0.92 1.09 12.1± 0.07 11.5± 0.08 2.99± 0.066 4.91± 0.031 4 1.39
Hst5ZM 1.13 1.23 12.8± 0.05 13.6± 0.02 3.12± 0.0052 5.24± 0.034 3 1.48
Hst52H 1.27 1.10 14.1± 0.04 12.9± 0.05 3.25± 0.048 3.44± 0.057 2 1.21
Hst5DH 1.08 1.07 13.9± 0.13 13.4± 0.05 3.45± 0.039 3.27± 0.056 0 0.96
(b)
NH Rh (Å) Rh,Zn (Å)
Hst5 7 12.9 ± 0.7 12.9 ± 0.3 a
Hst5RAN 7 12.9 ± 0.5 12.9 ± 0.3 a
Hst5DZM 4 13.1 ± 0.4 14.2 ± 0.4 b
Hst5ZM 3 13 ± 0.2 16.2 ± 0.9 b
Hst52H 2 13 ± 0.2 13.8 ± 0.4
Hst5DH 0 12.6 ± 0.6 13.3 ± 0.2
a Extensive line broadening in the NMR spectra; b Light line broadening in the NMR spectra.
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Figure 5. Kratky plots visualising the difference in shape between Hst5 in the absence and presence
of Zn2+. (A,B) shows Hst5, Hst5DZM, and Hst52H in the absence and presence of Zn2+, respectively.
(C,D) shows Hst5, Hst5RAN, and Hst5ZM in the absence and presence of Zn2+, respectively.
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The zinc-induced oligomerisation observed for WT Hst5 was evaluated by comparing the forward
scattering of the system in the absence and in the presence of Zn2+, normalised to the concentrations
as,
I0,zn/cp,Zn
I0/cp
; from now on denoted β. Here β=1.0 indicates no mass increase in the system i.e., no
oligomerisation, whereas β> 1 does. Comparing the β-values for WT Hst5 and HstRAN (Table 2)
showed that randomising the sequence decreased β from≈ 2.5 to 2, but did not abolish oligomerisation.
The effect of keeping the HExxH-motif and removing the histidines of the zinc-binding-like motif
(Hst5ZM) or vice versa (Hst5DZM), affected the oligomerisation to the same extent (β ≈ 1.4–1.5) in
agreement with the NMR diffusion experiments (14.2 ± 0.4 Å and 16.2 ± 0.9 Å for Hst5DZM and
Hst5ZM, respectively). These results suggest that while the order of the histidines may have a small
effect on oligomerisation, it is the number of histidines that is most important. In line with this,
no binding was detected by NMR (supporting information Figure S1), and thus no oligomerisation
(β ≈ 1) occurred for Hst5DH in which all histidines are removed. Accordingly, if only two histidines
remained in the sequence, Hst52H, oligomerisation occurred only to a very small extent (β ≈ 1.2).
Thus, a correlation between oligomerisation given by β, and the number of histidines, reveal a linear
relationship (Figure 6). Based on this we conclude that the order of histidines plays a less important
role in zinc binding and oligomerisation, whereas the number of histidines in the protein sequence
regulates the process.
0 1 2 3 4 5 6 7
Number of hisitdines
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β
Hst5DH
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Figure 6. Correlation between the number of histidines and oligomerisation of Hst5 in the presence
of Zn2+. The mass increase of the system defined as, β, see Equation (16), as a function of the number
of histidines. Here β=1.0 indicates no mass increase in the system i.e., no oligomerisation, whereas
β > 1 does.
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Since there were different degrees of mass increase corresponding to different sizes of oligomers
formed in the different variants, this hampered the analyses of shape and Rg’s. Even though Hst5 is a
short peptide, which decreases the probability to attain a large conformational ensemble, the variants
generally possessed a more extended shape than Zn2+ bound Hst5, as seen in the Kratky plots in
Figure 5. From the experimentally determined β-value, we noticed that upon addition of Zn2+,
oligomers were formed when at least two histidines were present. Analysing the Kratky plot showed
that Zn2+ addition resulted in a more compact shape, compared to a random coil (see Supplementary
Figure S2). Chain expansion or collapse can be probed by SAXS by analysing the fractal dimension at
intermediate q-range. In this region the intensity has a power law dependence on q, thus, by plotting
log(I) against log(q), the mass fractal dimension, Dm, can be determined [40]. Unlike Rg and Rh, Dm is
sensitive to the favourable or unfavourable solvation of the measured chains. Larger values of Dm
reflect unfavourable interactions with the solvent, and more compact conformations. Figure 7A,B
shows the linear fit for this region of the SAXS data for Hst5, as well as of the variants with a reduced
number of histidines, for both concentrations measured. We note that although this region is expected
to exist, the noise can be quite high and thus, we focused only on the high concentration measurements
(values of Dm obtained for low concentrations samples are shown in Supplementary Figure S3B,D).
In the absence of Zn2+, the measured Dm was invariant with the number of histidines. The estimated
Dm of about 1.6 observed for all variants, (Figure 7C), was close to the expected value of a well solvated
polymer (1.7), and agreed well with the shape observed in the Kratky plot [40]. Upon addition of Zn2+,
Dm increased for all of the Hst5 variants. This increase could be caused by either a collapse of the
polypeptide chain or the formation of oligomers. In the low concentration measurements, the observed
differences in Dm were primarily observable in WT Hst5, and some effects were noticed for the
randomised sequence. The increase is linear with the number of histidines present in the sequence
apart from His5RAN and His5DH. It is therefore more likely that the increase in Dm corresponds to
oligomer conformations of Hst5, which are less exposed to solvent [40]. To confirm this, the average
scattering envelopes were calculated from the P(r) functions using DAMMIF, see models in Figure 7E.
Typically for IDPs, this approach does not provide detailed information as the scattering from
a heterogeneous population yields an average of the entire population. However, we note that an
increase in the apparent scattering envelope would correspond to an increase in the average protein
size, caused by the contribution of an oligomeric population. Figure 7D shows the effects of Zn2+ on the
volume of the calculated scattering envelopes from different variants. The change in volume follows
the same trend as the change observed in the fractal dimension, hence we conclude that the observed
change in Dm is caused by the presence of oligomers, which have a more compact conformation.
A large increase in the volume of the scattering envelope was observed in WT Hst5 upon addition
of ZnCl2. This supports our previous observation suggesting that the presence of oligomerisation
is mediated by histidine-zinc interactions. This ability is increased when the histidine residues are
organised within a zinc-binding motif. Interestingly, the variant Hst5DH also became more compact
when Zn2+ was added to the solution as observed in the Dm values, and the increased volume. This is
also visible in Rg, which decreased from 13.9 => 13.4 Å.
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Figure 7. The effect of Zn2+ on the shape of Hst5 and selected variants (A) Log-Log plot of SAXS of
5 mg/mL Hst5 variants in the absence of Zn2+ (circles) and presence of Zn2+ (squares). The dashed lines
represent a fit of the power law relationship to the scattering data from which the fractal dimension
Dm was estimated. (B) The same plot as A shown for low concentration scattering data (1 mg/mL).
(C) Plot of Dm against the number of histidines present in the Hst5 variants in the absence of Zn2+
(red circles) and in the presence of Zn2+ (black crosses). (D) The volume of the scattering envelope,
in the presence and absence of Zn2+. The randomised sequence is shown as triangles where yellow
is in the absence of Zn2+ and blue in the presence. (E) Scattering envelopes produced by DAMMIF
corresponding to the volumes shown in Figure 7D.
3.2. Comparison with Computer Simulation
From the above experimental results it is plausible that the mechanism of Aβ oligomer formation
as proposed by Polshakov et al. [20] is applicable to Zn2+-coordination by Hst5. To address this, we
used our established coarse-grained model and Monte Carlo simulations with a slight modification,
that is, a short-ranged attractive interaction decaying as 1/r6 was implemented among the histidines
and the Zn2+-binding motif. In the simulations, the experimental concentrations were mimicked,
hence multibody interactions were taken into account. For example, a simulation box of 450 Å in X, Y,
and Z-directions, and a protein concentration of 1 mg/mL, corresponds to approximately 16 chains.
The scattering intensity curves for Hst5ZM, Hst5DZM, and Hst5 (Figure 8A–C, respectively) were
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modelled by applying a recent protocol [21], and compared to the experimental scattering data. There
was good agreement between the model and the experimental data (χ2) for Hst5 + Zn2+ ≈ 2.2. This
correspondence was also evident for the shape of the peptides, as visualised in the Kratky plot in
Figure 8D. The number average of the formed oligomers as a function of peptide concentration was
further analysed by simulations. As was shown in Table 2, β for Hst5DZM and Hst5ZM were similar
in size i.e., 1.4–1.5, whereas for Hst5 it was ≈ 2.5. From the simulations, the average oligomer size
was extracted (Figure 9A), supporting these observations and providing additional support that both
the HExxH-motif as well as the second histidine binding motif are needed for oligomer formation,
and that the most frequent average cluster size was between monomer and dimer.
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Figure 8. Comparison of experimental SAXS curves with those determined by computer simulation
for WT Hst5. The intensity function normalised by concentration, I(q)/c, and the corresponding
Kratky plot, q2 I(q)/I(0), for SAXS of Hst5 and Monte Carlo simulations, where Figures (A–C) depict
a comparison between the experimental SAXS-spectra of Hst5/variants and simulations, where the
additional short-ranged attractive interactions is taken into consideration. The χ2 of the fits to the data
are as follows (A) 2.2 (B) 1.9 and (C) 1.7. Figure D shows the SAXS data as a Kratky plot. Colours as in
(A–C). The data given in the Figure corresponds to a peptide concentration of ≈ 1 mg/mL.
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Figure 9. Distribution of oligomers determined by computer simulation for Hst5 and variants.
(A) Average cluster size for Hst5 and variants as indicated determined by computer simulation. Shown
for increasing concentrations of the respective protein.The scatter points correspond to the β values
determined for Hst5 from SAXS (red y-axis). (B) Distribution of the formed clusters obtained by
computer simulation, the bar chart corresponds to the determined Nass. Tetramer + corresponds to
tetrameric and higher oligomers. The scatter points correspond to the β values determined from SAXS
(red y-axis, as shown in Figure 7). The red and black dashed lines represents a β value of 1, i.e., a
monomeric protein.
The oligomers were further investigated by analysing the distribution of the formed clusters,
which gave an indication of the largest observed cluster (see Figure 9B). For a concentration of
2.8 mg/mL Hst5, there was > 1% probability for pentamer formation, where the main part
corresponded to monomers (82%) and dimers (9%). For the variants Hst5DZM and Hst5ZM, the main
contribution came from monomers (95%), with approximately 4% of dimers. Hence, this once again
confirms that the cooperation of histidines play an important role for the formation of clusters, their
average size, and their polydispersity. Furthermore, considering the small population of oligomers,
these results suggest that the compaction observed occurs in the monomer. As was stated above,
the size of the oligomers was dependent on the peptide concentration, which was also the case for the
polydispersity. For example, simulation of approximately 1 mg/mL Hst5 gives 94% monomers, 5.5%
dimers, and 0.5% trimers. There was a slight but very low probability that oligomers of the size of
pentamers formed. Comparison with the β value obtained by SAXS showed a good agreement with
the oligomer distributions obtained by computer simulation (Figure 9). Thus, in conclusion, we find
that Hst5 forms dynamic oligomers in the presence of Zn2+ in which a compact monomer dominates,
followed by a concentration dependent increase in the size of oligomers, with the dimer being the
second most dominant species.
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3.3. Stoichiometry, Coordination And Thermodynamics
To understand the thermodynamics as well as mapping the stoichiometry of Zn2+-binding to Hst5,
we employed isothermal titration calorimetry, Figure 10, and included the two variants where each of
the zinc-binding motifs were knocked out, Hst5DZM and Hst5ZM (Table 1). The WT Hst5 bound Zn2+
with µM affinity (Kd = 26 µM) and was mainly enthalpically driven with a minor entropic contribution.
Despite the two potential Zn2+ binding sites in WT Hst5, the binding stoichiometry for the interaction
with Zn2+ was one suggesting either 1:1 or 2:2 binding. The simulations suggested a very small
oligomer population making a 1:1 binding or a mix between 1:1 and 2:2 binding between Hst5 and
Zn2+ most likely. In solution Zn2+ is most often octahedrally coordinated to water, however, in protein
complexes, tetrahedral coordination is by far most dominant [41,42]. In structural stabilisation, four
protein ligands are most common whereas in many enzymes three protein ligands in conjunction with
water or some other solvent molecule prevails [41–43]. Despite almost equal presence of histidines
and cysteines in Zn2+ coordination, no structures with four coordinating histidines (His4) were
reported by Laitaoja et al. [41] Instead histidines often coordinate Zn2+ in combination with an
acidic residue (i.e., glutamate or aspartate), whereas Cys4 coordination is most common in several
protein classes [41]. Despite this, His4 coordination has previously been reported for Aβ where it is
responsible for inter-peptide aggregation [44]. While it is likely that His4 coordination plays a similar
role for Hst5 oligomerisation, it is possible that other residues than histidine such as the glutamate
from the HEXXH motif are involved in the compaction of Hst5, thereby contributing to the observed
line broadening. The fact that we see no dual Zn2+ binding to Hst5 likely reflects the fact that it is more
energetically favourable for Zn2+ to be coordinated by four histidines rather than three histidines and a
water molecule [45]. Interestingly the two single motif variants Hst5DZM and Hst5ZM both bound Zn2+
with an affinity similar to that of WT Hst5. While this may not be surprising given the similarity of the
two motifs, the thermodynamic profile of the two types of interactions were very different, whereas
the WT Hst5 interaction was mainly driven by enthalpic contributions, the interactions with the two
single motif variants were driven by a large entropic contribution likely caused by desolvation and
release of counter-ions. While the same desolvation occurs in the case of WT Hst5, the compaction
resulting in less rotational freedom for the WT Hst5 termini, bears a large entropic cost. Furthermore,
the compaction of WT Hst5 likely also induces a number of inter-molecular interactions that are not
formed in the single motif variants, perhaps involving the two aromatic residues between the motifs,
thus explaining the difference in enthalpic contribution in the two types of interactions.
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Figure 10. ITC measurements of interactions between Hst5 variants and Zn2+. Plots showing
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4. Conclusions
4.1. Underlying Mechanism of The Oligomerisation
The combined results obtained from SAXS, NMR, calorimetry, and simulations jointly support a
coherent mechanism for how Zn2+ mediates oligomer formation of Hst5. Initially, Zn2+ can bind to any
of the two binding motifs forming a one-to-one complex with similar affinity, as seen in the two variants
Hst5DZM and Hst5ZM. Likely, in a 1:1 complex with WT Hst5, Zn2+ would be coordinated by histidines
from both motifs, leading to compaction. Once Zn2+ is bound, and the concentration increases, dimers
are formed across two Hst5 chains, maintaining the 1:1 (2:2) stoichiometry, but with the possibility for
more than one distinct coordination, giving rise to the observed severe line broadening. These dimers
can then act as seeds and through interactions via networks of histidine:Zn2+ coordination, form
higher ordered oligomers, although at a much lower population. This is in line with the suggested
mechanism of oligomerisation of the Aβ1-16 region [20]. Hence it seems plausible that the dimerisation
as well as the oligomerisation of Hst5 follows the same underlying mechanism as that proposed for
the Aβ peptide [29] i.e., the initial binding between Hst5 and Zn2+ for the single peptide is through
the residues H7/H8 and the amino acids in the zinc motif, E16, H18, and H19. Thereafter dimers are
formed through coordination of Zn2+ between E16 and H19 on respective peptide, whereas finally
oligomers are formed by dynamic coordination of the dimers through the histidines H7/H8 and H18,
see Figure 11.
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Figure 11. Schematic depiction of the mechanism of Zn2+ induced oligomerisation of Hst5.
By entropic reasons, one can expect that it is the middle region of Hst5 that constitutes the
preferred seed, since it will be more favourable for the system if the peptide ends remain unrestricted.
This is supported by the thermodynamics measurements, as we see a much lower entropic penalty
when either of the two motifs are mutated, whereas once both motifs are operational, a large entropic
cost in Zn2+ binding is measured, compensated by much larger enthalpic gain. This mechanism
i.e., that all histidines are involved in the dimerisation and oligomerisation process, is also in line with
what Blindauer et al. [46] have seen for the histidine-rich glycoprotein HRGP330. By using NMR,
they noticed a uniform line broadening of all histidine sidechains and most backbone resonances
upon addition of a single molar equivalent of Zn2+, suggesting that there is no clear preferential
biding site, and that the system contains several species in exchange on an intermediate NMR time
scale. Furthermore, at high stoichiometric ratios of Zn2+/HRGP330, precipitation occurred, in line
with our observations for Hst5. Furthermore, it has been suggested that the mechanism by which
Zn2+ is expected to induce the formation of oligomers is via coordination to the N1 atom of the
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imidazole ring of the histidine, which causes cross-linking of the peptide through intermolecular
His(N1)-Zn2+-His(N1) bridges [47]. This also provides the possibility for a dynamic coordination
process, which as such might explain the line-broadening visible in the NMR experiments of Hst5.
Finally, the dynamic interchange between different complexes with similar affinity allows Hst5 to
act as a metal-ion buffering system in the mouth, where release and binding can be controlled
thermodynamically, without leading to severe, and potentially toxic aggregation.
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Supplemental Figure S1: 1H 1D NMR spectra of the aromatic region of Hst5 under different conditions and
variants. Supplemental Figure S2: Kratky plots visualising the difference in shape between Hst5 in the absence
and presence of zinc. Supplemental Figure S3: The effect of zinc on the shape of Histatin 5 and selected variants.
Supplemental Figure S4: Fits calculated from the DAMMIF scattering envelope shown for each measured sample.
Supplemental Figure S5: Representative diffusion data measured on Wt Hst5 A) with and B) without Zn2+ added.
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